The superfamily of IGF binding proteins extends to a further ten proteins known as IGFBP-rPs that also bind IGFs, albeit at much lower affinities than the IGFBPs [23,24] (Table 1, Figure 2)
We critically evaluate clinical evidence across major liver diseases, including viral hepatitis, drug-induced liver injury, alcoholic liver disease, non-alcoholic fatty liver disease, and autoimmune hepatitis, while highlighting heterogeneity in study designs, geographical concentration of evidence, and the predominance of positive findings that may reflect publication bias
Ben Blanc 21:37 Well, thanks, Peter, and thats actually a great transition, because all these programs that you mentioned, all these changes at the end of the day, they will impact the patients
are tremendous forms of both EPA/DHA and carnitine